ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.
NCT ID: NCT00509392
Last Updated: 2017-07-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
69 participants
INTERVENTIONAL
2007-03-31
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ClosureFAST - Radiofrequency Great Saphenous Vein Treatment
NCT00842296
Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein
NCT02236338
VeClose Five Year Follow-Up Extension Study
NCT03455699
Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous Vein
NCT01173419
VenaSeal Sapheon Closure System Pivotal Study (VeClose)
NCT01807585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Seg. RF Ablation & ClosureFAST catheter
Seg. RF Ablation \& ClosureFAST catheter
Seg. RF Ablation & ClosureFAST catheter
Seg. RF Ablation \& ClosureFAST catheter
Endovenous Laser
Treatment invention of venous disease with an Endovenous Laser.
Endovenous Laser
laser catheter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Seg. RF Ablation & ClosureFAST catheter
Seg. RF Ablation \& ClosureFAST catheter
Endovenous Laser
laser catheter
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be a candidate for either treatment with Radiofrequency Ablation (RFA) or endovenous laser.
Exclusion Criteria
* Subjects who are participating in another investigational study.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VNUS Medical Technologies, A Covidien Company
INDUSTRY
Medtronic Endovascular
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lian Cunningham, MD
Role: STUDY_DIRECTOR
VNUS Medical Technologies, A Covidien Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health Sciences
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Almeida JI, Kaufman J, Gockeritz O, Chopra P, Evans MT, Hoheim DF, Makhoul RG, Richards T, Wenzel C, Raines JK. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol. 2009 Jun;20(6):752-9. doi: 10.1016/j.jvir.2009.03.008. Epub 2009 Apr 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CVL-06-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.